R. Oshima et al., PROBUCOL TREATMENT ATTENUATES THE AORTIC ATHEROSCLEROSIS IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS, Atherosclerosis, 137(1), 1998, pp. 13-22
We examined the effect of probucol on the aortic atherosclerosis alrea
dy developed in Watanabe heritable hyperlipidemic (WHHL) rabbits at th
e initiation of treatment. In WHHL rabbits treated with probucol for 5
months from 8 months old, the lesion area in the aorta was significan
tly (P<0.05) reduced when compared with that in untreated animals as w
ell as animals at age 8 months. In contrast, plasma cholesterol levels
in the probucol-treated group and untreated group during the experime
nt were not significantly different. LDL prepared from rabbits receivi
ng probucol for 5 months showed resistance to oxidation by copper ions
. Plasma CETP activity was significantly (P<0.05) increased by probuco
l treatment. An immunohistochemical study showed that macrophages were
abundant in the atherosclerotic lesions of untreated rabbits whereas
smooth muscle cells were predominant in lesions of probucol-treated ra
bbits. These results suggest that the atherosclerotic lesion in WHHL r
abbits can regress when treated by probucol and that the attenuation o
f atherosclerosis in this animal involves effects of probucol other th
an a decrease in plasma cholesterol, for example anti-oxidant activity
. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.